Dr. Reddy's Laboratories Limited (RDY) earnings: date, estimates, results and stock reactions
Next earnings: Q3 FY2027 on 2027-01-22 (expected, time not announced). EPS estimate 11.90, revenue estimate 90.61B.
Over the last 12 reports the stock moved 2.6% on average (either way), rising 5 times and falling 7. EPS beat estimates 7 of 12 times; revenue 9 of 12. Close before the report date to the first close after it (two trading sessions, covering before-the-open and after-the-close reports).
| Quarter | Reported | EPS | EPS estimate | EPS surprise | Revenue | Revenue estimate | Stock move |
|---|---|---|---|---|---|---|---|
| Q2 FY2027 | 2026-10-23 | 11.10 | 9.21 | +20.5% | 85.60B | 86.20B | +5.8% |
| Q1 FY2027 | 2026-07-21 | 5.33 | 8.83 | -39.6% | 82.08B | 81.09B | -3.3% |
| Q4 FY2026 | 2026-05-11 | 2.64 | 11.06 | -76.1% | 75.16B | 82.33B | -1.8% |
| Q3 FY2026 | 2026-01-20 | 14.52 | 13.76 | +5.5% | 87.27B | 83.58B | -0.9% |
| Q2 FY2026 | 2025-10-24 | 17.22 | 16.81 | +2.4% | 87.10B | 86.82B | +0.4% |
| Q1 FY2026 | 2025-07-23 | 17.04 | 18.38 | -7.3% | 86.15B | 87.01B | +2.1% |
| Q4 FY2025 | 2025-05-09 | 19.09 | 18.16 | +5.1% | 84.96B | 83.87B | +4.1% |
| Q3 FY2025 | 2025-01-23 | 16.94 | 17.91 | -5.4% | 83.59B | 81.76B | -5.5% |